NPI: 1891892741 · MAYFIELD, KY 42066 · Pediatrics Physician · NPI assigned 09/20/2006
Authorized official LAWRENCE, CHARLOTTE controls 20+ related entities in our dataset. Read more
| Authorized Official | LAWRENCE, CHARLOTTE (SECRETARY) |
| NPI Enumeration Date | 09/20/2006 |
Other providers sharing the same authorized official: LAWRENCE, CHARLOTTE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 139,360 | $8.73M |
| 2019 | 144,887 | $7.33M |
| 2020 | 129,901 | $5.18M |
| 2021 | 136,071 | $5.45M |
| 2022 | 129,761 | $5.40M |
| 2023 | 129,778 | $6.03M |
| 2024 | 107,240 | $5.23M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 24,738 | 19,980 | $5.80M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 33,816 | 27,681 | $4.61M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 8,248 | 5,595 | $3.01M |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 3,885 | 2,936 | $2.60M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2,777 | 2,291 | $2.14M |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 4,978 | 4,597 | $1.71M |
| 70450 | Computed tomography, head or brain; without contrast material | 5,583 | 4,075 | $1.47M |
| G0378 | Hospital observation service, per hour | 2,773 | 2,023 | $1.44M |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 3,490 | 2,486 | $1.27M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 10,860 | 9,707 | $1.15M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 21,235 | 5,405 | $888K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 9,473 | 6,908 | $819K |
| 96375 | Therapeutic injection; each additional sequential IV push | 5,833 | 4,619 | $714K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 17,588 | 4,338 | $580K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 17,329 | 12,185 | $558K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 4,924 | 2,450 | $527K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 4,746 | 4,152 | $502K |
| 96361 | Intravenous infusion, hydration; each additional hour | 18,036 | 5,322 | $474K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 1,033 | 873 | $460K |
| 36415 | Collection of venous blood by venipuncture | 122,889 | 50,040 | $424K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 8,271 | 2,835 | $408K |
| 80053 | Comprehensive metabolic panel | 48,799 | 34,575 | $399K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 2,229 | 1,998 | $370K |
| 73630 | 6,027 | 4,570 | $360K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 48,766 | 38,714 | $353K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 7,667 | 6,335 | $333K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 6,093 | 4,897 | $299K |
| 72125 | Computed tomography, cervical spine; without contrast material | 845 | 675 | $291K |
| 59025 | Fetal non-stress test | 3,723 | 1,691 | $268K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 7,460 | 2,720 | $265K |
| 73030 | 3,704 | 2,740 | $258K | |
| 71045 | Radiologic examination, chest; single view | 12,965 | 8,087 | $256K |
| 73562 | 3,529 | 2,616 | $240K | |
| 73610 | 3,270 | 2,603 | $236K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | 745 | 564 | $233K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 4,913 | 1,498 | $223K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1,381 | 1,145 | $216K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 8,567 | 7,022 | $212K |
| 73130 | 2,886 | 2,265 | $193K | |
| 73110 | 2,325 | 1,806 | $183K | |
| 71046 | Radiologic examination, chest; 2 views | 7,022 | 5,328 | $181K |
| 72131 | 626 | 447 | $179K | |
| 97597 | 2,592 | 1,053 | $172K | |
| 84443 | Thyroid stimulating hormone (TSH) | 12,519 | 11,551 | $170K |
| 76770 | 2,000 | 1,759 | $162K | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | 11,016 | 2,737 | $162K |
| 72110 | 2,101 | 1,597 | $153K | |
| 87486 | 5,947 | 4,683 | $149K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 5,025 | 4,655 | $146K |
| 87581 | 4,967 | 4,603 | $144K | |
| 71250 | 594 | 519 | $137K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 3,800 | 2,981 | $130K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 498 | 468 | $130K |
| 95886 | 1,925 | 1,802 | $122K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 5,971 | 5,516 | $121K |
| 80061 | Lipid panel | 10,950 | 10,031 | $114K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1,155 | 1,016 | $113K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1,556 | 1,351 | $111K |
| 72050 | 1,054 | 789 | $104K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 3,541 | 3,270 | $103K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 218 | 179 | $97K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 2,950 | 1,277 | $94K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1,157 | 468 | $94K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 901 | 517 | $93K |
| 97162 | 1,748 | 1,453 | $90K | |
| 74018 | 2,124 | 1,843 | $88K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 5,565 | 3,252 | $85K |
| 83735 | 15,439 | 12,476 | $80K | |
| 82805 | 1,735 | 1,287 | $76K | |
| 81025 | 7,188 | 6,329 | $71K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 9,999 | 9,142 | $68K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 9,093 | 7,803 | $64K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1,218 | 1,137 | $63K |
| 84484 | 6,185 | 4,806 | $63K | |
| 97161 | 1,166 | 1,050 | $61K | |
| 80081 | 996 | 931 | $61K | |
| 83880 | 2,511 | 1,855 | $60K | |
| 81003 | 12,472 | 10,351 | $58K | |
| 81001 | 10,401 | 8,913 | $57K | |
| 96376 | 1,106 | 755 | $53K | |
| 82607 | 4,281 | 3,957 | $51K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 6,262 | 4,617 | $45K |
| 73564 | 550 | 437 | $44K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 173 | 90 | $44K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1,642 | 1,436 | $42K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 848 | 567 | $41K |
| 73080 | 514 | 397 | $41K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1,877 | 1,789 | $40K |
| 87040 | 2,546 | 2,001 | $39K | |
| 73502 | 2,387 | 1,708 | $38K | |
| J2704 | Injection, propofol, 10 mg | 8,833 | 7,793 | $38K |
| 83690 | 6,407 | 5,399 | $37K | |
| 84439 | 4,950 | 4,608 | $36K | |
| 93971 | 332 | 287 | $35K | |
| 87186 | 3,917 | 3,376 | $35K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 10,922 | 9,364 | $35K |
| 95911 | 381 | 314 | $35K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1,957 | 1,573 | $35K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 97 | 65 | $35K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 86 | 68 | $34K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1,159 | 1,051 | $33K |
| 84481 | 2,413 | 2,237 | $32K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1,121 | 1,021 | $32K |
| 82150 | 5,649 | 4,772 | $32K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 130 | 105 | $32K |
| 82962 | 5,224 | 2,784 | $30K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 6,164 | 4,929 | $30K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 181 | 168 | $30K |
| 87077 | 5,862 | 3,657 | $29K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 2,894 | 2,630 | $29K |
| 70486 | 80 | 75 | $29K | |
| J0690 | Injection, cefazolin sodium, 500 mg | 3,307 | 2,496 | $28K |
| 76536 | 213 | 185 | $28K | |
| 85610 | 5,898 | 4,515 | $27K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 2,693 | 2,052 | $26K |
| 83605 | 2,859 | 2,200 | $26K | |
| 92526 | 783 | 237 | $26K | |
| 93017 | 222 | 186 | $25K | |
| 84145 | 1,444 | 1,024 | $25K | |
| 86850 | 1,928 | 1,601 | $23K | |
| 72114 | 393 | 308 | $22K | |
| 85730 | 3,366 | 2,746 | $22K | |
| 86696 | 1,402 | 1,335 | $22K | |
| 86003 | 197 | 187 | $21K | |
| 99215 | Prolong outpt/office vis | 335 | 311 | $20K |
| 73560 | 371 | 282 | $19K | |
| 87070 | 2,915 | 1,848 | $19K | |
| 97035 | 747 | 277 | $19K | |
| 73590 | 258 | 202 | $19K | |
| 74022 | 274 | 235 | $19K | |
| 12001 | 97 | 90 | $18K | |
| 85379 | 2,155 | 1,922 | $18K | |
| 87205 | 2,005 | 1,626 | $17K | |
| 86694 | 1,301 | 1,233 | $17K | |
| 87088 | 2,694 | 2,385 | $17K | |
| 82565 | 1,605 | 1,148 | $17K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 5,642 | 4,846 | $17K |
| 84703 | 2,080 | 1,873 | $17K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1,096 | 1,025 | $17K |
| 29125 | 162 | 152 | $17K | |
| 87081 | 2,402 | 2,183 | $16K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 1,589 | 1,492 | $16K |
| 80074 | 410 | 382 | $16K | |
| 87507 | 59 | 55 | $16K | |
| G0475 | Hiv antigen/antibody, combination assay, screening | 724 | 665 | $16K |
| 84702 | 1,156 | 766 | $15K | |
| 72100 | 242 | 201 | $15K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 1,584 | 942 | $14K |
| 82728 | 1,425 | 1,228 | $14K | |
| 73090 | 191 | 159 | $14K | |
| 86140 | 3,127 | 2,561 | $14K | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 1,141 | 995 | $13K |
| 36600 | 1,792 | 968 | $13K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 380 | 275 | $13K |
| 73140 | 200 | 168 | $13K | |
| 87634 | 204 | 186 | $12K | |
| 90715 | 565 | 516 | $12K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 11,279 | 9,133 | $12K |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 572 | 487 | $11K |
| 83540 | 1,970 | 1,850 | $11K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 616 | 541 | $11K |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 970 | 874 | $10K |
| 84403 | 500 | 466 | $10K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 1,265 | 1,067 | $9K |
| J2270 | Injection, morphine sulfate, up to 10 mg | 3,612 | 2,744 | $9K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 1,440 | 1,223 | $9K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 5,299 | 4,515 | $9K |
| 76830 | Ultrasound, transvaginal | 57 | 51 | $9K |
| 83550 | 1,177 | 1,098 | $8K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 5,219 | 4,561 | $8K |
| 80055 | 138 | 136 | $8K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 28 | 26 | $7K |
| 82550 | 1,500 | 1,307 | $7K | |
| 78227 | 12 | 12 | $7K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 3,577 | 2,842 | $7K |
| 86900 | 2,522 | 1,814 | $6K | |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 1,510 | 1,291 | $6K |
| J1170 | Injection, hydromorphone, up to 4 mg | 2,950 | 2,306 | $6K |
| 71101 | 155 | 92 | $6K | |
| 92523 | 36 | 31 | $6K | |
| 86039 | 607 | 566 | $6K | |
| 85652 | 1,834 | 1,501 | $6K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 152 | 142 | $6K |
| 83970 | 165 | 157 | $6K | |
| 72070 | 56 | 39 | $5K | |
| 86901 | 2,158 | 1,788 | $5K | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 35 | 35 | $5K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 4,441 | 3,962 | $5K |
| 84550 | 1,218 | 1,061 | $5K | |
| 95909 | 101 | 74 | $5K | |
| 82950 | 1,071 | 1,011 | $4K | |
| J2060 | Injection, lorazepam, 2 mg | 2,390 | 1,976 | $4K |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 426 | 352 | $4K |
| 76642 | 45 | 41 | $4K | |
| M0245 | Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring | 21 | 18 | $4K |
| 87807 | 265 | 253 | $4K | |
| J3480 | Injection, potassium chloride, per 2 meq | 235 | 103 | $3K |
| 72040 | 41 | 39 | $3K | |
| 76870 | 14 | 12 | $3K | |
| J2785 | Injection, regadenoson, 0.1 mg | 33 | 33 | $3K |
| J2550 | Injection, promethazine hcl, up to 50 mg | 2,350 | 1,976 | $3K |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | 161 | 146 | $3K |
| 82627 | 144 | 137 | $3K | |
| 95910 | 31 | 26 | $3K | |
| 84436 | 121 | 113 | $3K | |
| 84146 | 147 | 132 | $2K | |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | 61 | 57 | $2K |
| 82746 | 184 | 177 | $2K | |
| 84402 | 111 | 104 | $2K | |
| J1815 | Injection, insulin, per 5 units | 194 | 105 | $2K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 1,765 | 1,535 | $2K |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 224 | 193 | $2K |
| 82105 | 133 | 123 | $2K | |
| 84156 | 696 | 619 | $2K | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 345 | 278 | $2K |
| 82570 | 493 | 429 | $2K | |
| 87899 | 64 | 62 | $2K | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 93 | 80 | $2K |
| 82652 | 50 | 48 | $2K | |
| 73060 | 17 | 12 | $1K | |
| 84100 | 322 | 196 | $1K | |
| J3490 | Unclassified drugs | 620 | 460 | $1K |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | 191 | 129 | $1K |
| 87506 | 14 | 12 | $1K | |
| A9537 | Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries | 13 | 13 | $1K |
| 83525 | 143 | 138 | $1K | |
| 83001 | 81 | 77 | $1K | |
| 87075 | 150 | 125 | $1K | |
| 92587 | 21 | 18 | $1K | |
| 80164 | 128 | 103 | $1K | |
| 80069 | 107 | 90 | $1K | |
| 86695 | 101 | 97 | $1K | |
| 97012 | 28 | 12 | $966.94 | |
| 82670 | 47 | 43 | $964.81 | |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | 32 | 24 | $946.11 |
| 93270 | 77 | 65 | $925.83 | |
| 74019 | 18 | 12 | $848.10 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 184 | 171 | $824.86 |
| J7510 | Prednisolone oral, per 5 mg | 116 | 103 | $751.40 |
| J2805 | Injection, sincalide, 5 micrograms | 12 | 12 | $712.92 |
| 82140 | 58 | 52 | $693.46 | |
| 83630 | 33 | 29 | $678.67 | |
| 86592 | 187 | 182 | $675.50 | |
| 87522 | Neg quan hep c or qual rna | 13 | 12 | $634.94 |
| 82553 | 72 | 57 | $624.50 | |
| 86376 | 56 | 53 | $591.79 | |
| 71271 | 33 | 33 | $581.69 | |
| 86431 | 110 | 106 | $479.84 | |
| 82010 | 75 | 52 | $424.22 | |
| 83655 | 39 | 38 | $415.77 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 144 | 133 | $413.93 |
| J3230 | Injection, chlorpromazine hcl, up to 50 mg | 29 | 25 | $387.32 |
| 87045 | 33 | 32 | $383.34 | |
| 82947 | 110 | 102 | $364.83 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 305 | 267 | $343.44 |
| 84681 | 13 | 13 | $330.32 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 204 | 63 | $288.99 |
| 82043 | 64 | 59 | $277.22 | |
| 87210 | 56 | 49 | $269.36 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 269 | 242 | $254.66 |
| 84482 | 18 | 16 | $231.36 | |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 89 | 12 | $231.01 |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 40 | 25 | $229.49 |
| 83789 | 18 | 16 | $222.03 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 15 | 12 | $205.29 |
| J3360 | Injection, diazepam, up to 5 mg | 16 | 13 | $188.17 |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 15 | 12 | $186.74 |
| 86800 | 14 | 14 | $180.90 | |
| 83002 | 12 | 12 | $149.45 | |
| 82575 | 36 | 26 | $136.35 | |
| 87177 | 14 | 13 | $134.87 | |
| 86787 | 13 | 12 | $130.04 | |
| 80076 | 13 | 12 | $112.99 | |
| 84630 | 15 | 13 | $100.08 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 21 | 12 | $94.92 |
| 85018 | 46 | 43 | $86.53 | |
| 86308 | 17 | 17 | $74.14 | |
| 82044 | 12 | 12 | $70.41 | |
| J1171 | Injection, hydromorphone, 0.1 mg | 61 | 52 | $60.94 |
| J3410 | Injection, hydroxyzine hcl, up to 25 mg | 13 | 13 | $55.21 |
| 85014 | 27 | 26 | $54.26 | |
| Q0244 | Injection, casirivimab and imdevimab, 1200 mg | 129 | 120 | $41.25 |
| J7050 | Infusion, normal saline solution, 250 cc | 14 | 12 | $36.12 |
| A9270 | Non-covered item or service | 24 | 12 | $0.00 |